NQVAX | VMVAX | NQVAX / VMVAX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 22 years | 13 years | - |
Gain YTD | 21.565 | 17.355 | 124% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 3000 | 83% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 528M | 30.9B | 2% |
Annual Yield % from dividends | 0.98 | 2.14 | 46% |
Returns for 1 year | 30.15 | 27.09 | 111% |
Returns for 3 years | 37.01 | 13.54 | 273% |
Returns for 5 years | 82.23 | 47.45 | 173% |
Returns for 10 years | 144.40 | 96.84 | 149% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
CIOIX | 17.09 | -0.04 | -0.23% |
Causeway International Opps Inst | |||
APHNX | 15.79 | -0.05 | -0.32% |
Artisan Select Equity Institutional | |||
AGVGX | 23.72 | -0.25 | -1.04% |
American Funds Global Insight F-2 | |||
STMGX | 31.99 | -0.48 | -1.48% |
American Beacon Stephens Mid-Cap Gr Inv | |||
UGLSX | 85.15 | -1.94 | -2.23% |
JHancock U.S. Global Leaders Growth R6 |